We are live on !
Find out more
LPC
Loeb Partners Corp Portfolio holdings
AUM
$4.86M
Turnover
54.46%
1-Year Est. Return
7.22%
This Fund
S&P 500
This Quarter Est. Return
+13.67%
1 Year Est. Return
+7.22%
3 Year Est. Return
+34.39%
5 Year Est. Return
+90.55%
10 Year Est. Return
–
AUM
$4.86M
AUM Growth
-$210M
(-98%)
Cap. Flow
-$220M
Cap. Flow % of AUM
Cap. Flow %
-4,519.26%
Top 10 Holdings %
Top 10 Hldgs %
46.43%
Holding
336
New
4
Increased
3
Reduced
95
Closed
179
Avg Time Held
1.2
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$32.5K |
| 2 |
Cisco
CSCO
|
+$21.9K |
| 3 |
Moderna
MRNA
|
+$14.8K |
| 4 |
Alexandria Real Estate Equities
ARE
|
+$6.58K |
| 5 |
Nektar Therapeutics
NKTR
|
+$5.93K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$9.9M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$9.9M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$9.39M |
| 4 |
Bank of New York Mellon
BNY
|
+$8M |
| 5 |
Diageo
DEO
|
+$7.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.3% |
| 2 | Technology | 22.52% |
| 3 | Financials | 13.63% |
| 4 | Communication Services | 8.88% |
| 5 | Consumer Staples | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Thermo Fisher Scientific
TMO
$251B
| $428K | 8.8% |
1,570
-250
| -14% | -$62.2K |
2018 Q1
4 quarters
|
|
2
Microsoft
MSFT
$3.96T
| $354K | 7.28% |
3,000
-36,620
| -92% | -$4M |
2013 Q4
21 quarters
|
|
|
3
Berkshire Hathaway Class A
BRK.A
$1.14T
| $301K | 6.19% |
1
-31
| -97% | -$9.39M |
2013 Q2
23 quarters
|
|
4
Apple
AAPL
$5T
| $212K | 4.36% |
4,460
-6,000
| -57% | -$255K |
2017 Q1
8 quarters
|
|
5
Meta Platforms (Facebook)
META
$1.79T
| $211K | 4.34% |
1,255
-8,650
| -87% | -$1.38M |
2014 Q3
18 quarters
|
|
|
6
Berkshire Hathaway Class B
BRK.B
$1.14T
| $201K | 4.13% |
1,000
-49,000
| -98% | -$9.9M |
2015 Q2
15 quarters
|
|
7
IBM
IBM
$224B
| $187K | 3.85% |
1,386
-105
| -7% | -$13.4K |
2018 Q3
2 quarters
|
|
|
8
Alexandria Real Estate Equities
ARE
$6.91B
| $148K | 3.04% |
1,030
+50
| +5% | +$6.58K |
2018 Q4
1 quarter
|
|
9
Danaher
DHR
$158B
| $112K | 2.3% |
959
| – | – |
2018 Q4
1 quarter
|
|
10
Eli Lilly
LLY
$1.11T
| $104K | 2.14% |
800
-10,400
| -93% | -$1.26M |
2016 Q4
9 quarters
|
|
11
Merck
MRK
$357B
| $104K | 2.14% |
1,310
-105
| -7% | -$7.85K |
2018 Q4
1 quarter
|
|
12
General Dynamics
GD
$92.6B
| $84K | 1.73% |
500
-100
| -17% | -$16.8K |
2018 Q4
1 quarter
|
|
13
Pfizer
PFE
$168B
| $81K | 1.67% |
2,045
-6,403
| -76% | -$256K |
2018 Q2
3 quarters
|
|
14
Walmart Inc
WMT
$945B
| $80K | 1.65% |
2,400
-300
| -11% | -$9.7K |
2018 Q4
1 quarter
|
|
15
Procter & Gamble
PG
$367B
| $71K | 1.46% |
690
-39,100
| -98% | -$3.81M |
2013 Q2
23 quarters
|
|
16
AT&T
T
$160B
| $71K | 1.46% |
2,972
-126,273
| -98% | -$2.9M |
2013 Q2
23 quarters
|
|
17
Johnson & Johnson
JNJ
$613B
| $66K | 1.36% |
475
-29,700
| -98% | -$3.98M |
2013 Q2
23 quarters
|
|
18
Bristol-Myers Squibb
BMY
$121B
| $62K | 1.27% |
1,300
-260
| -17% | -$13K |
2018 Q4
1 quarter
|
|
19
Nike
NKE
$55.1B
| $62K | 1.27% |
750
-300
| -29% | -$24.8K |
2018 Q4
1 quarter
|
|
|
20
Cisco
CSCO
$422B
| $59K | 1.21% |
1,100
+450
| +69% | +$21.9K |
2018 Q1
4 quarters
|
|
21
Agilent Technologies
A
$48.3B
| $56K | 1.15% |
700
-200
| -22% | -$15.2K |
2018 Q4
1 quarter
|
|
22
SPDR Gold Trust
GLD
$140B
| $55K | 1.13% |
450
-27,313
| -98% | -$3.36M |
2013 Q2
23 quarters
|
|
23
Box
BOX
$5.56B
| $54K | 1.11% |
2,700
-400
| -13% | -$8.29K |
2018 Q4
1 quarter
|
|
24
AbbVie
ABBV
$502B
| $52K | 1.07% |
650
-2,120
| -77% | -$173K |
2016 Q4
9 quarters
|
|
25
Marvell Technology
MRVL
$213B
| $49K | 1.01% |
2,450
-300
| -11% | -$5.61K |
2018 Q4
1 quarter
|
|
Similar funds
CCM
CAM
TCM
PGC
SGS
ACM
HMPV
Loeb Partners Corp's Q1 2019 Portfolio in Review
As of Q1 2019, Loeb Partners Corp held 336 positions worth $4.86M, down 98% from $215M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Loeb Partners Corp withdrew a net $220M in Q1 2019, closing 179 positions and reducing 95 holdings. Its most notable exit was iShares S&P 500 Value ETF, an estimated $4.55M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 6.3% a quarter earlier, followed by Technology and Financials.
Against the trend, Loeb Partners Corp opened a new position in Unilever worth $36K.
- Loeb Partners Corp's largest Q1 2019 buy was Unilever: 533 shares worth $36K.
- Loeb Partners Corp added most to Cisco in Q1 2019, an estimated $21.9K increase.
- Loeb Partners Corp's biggest Q1 2019 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $9.9M.
- Loeb Partners Corp fully exited iShares S&P 500 Value ETF in Q1 2019, selling an estimated $4.55M.
- Loeb Partners Corp's ten largest holdings make up 46% of its $4.86M portfolio in Q1 2019.
- Loeb Partners Corp opened 4 new positions and closed 179 in Q1 2019.
- Loeb Partners Corp's portfolio value fell 98% quarter-over-quarter to $4.86M.
Based on Loeb Partners Corp's 13F filing for Q1 2019, filed 14 May 2019.